These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23212718)

  • 21. Prevalence and risk factors for aspirin and clopidogrel resistance in patients with coronary artery disease or ischemic cerebrovascular disease.
    Kim H; Lee HK; Han K; Jeon HK
    Ann Clin Lab Sci; 2009; 39(3):289-94. PubMed ID: 19667414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 23. Platelet aggregation and recruitment with aspirin-clopidogrel therapy.
    Helgason CM; Grossi E; Pandey D; Valika A; Cursio J; Brace LD
    Cerebrovasc Dis; 2008; 25(5):392-400. PubMed ID: 18349532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    Catella-Lawson F; Reilly MP; Kapoor SC; Cucchiara AJ; DeMarco S; Tournier B; Vyas SN; FitzGerald GA
    N Engl J Med; 2001 Dec; 345(25):1809-17. PubMed ID: 11752357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enteric-coated aspirin: review shows similar inhibition of platelet aggregation to ordinary dispersible aspirin.
    Cardiovasc J S Afr; 2007; 18(1):41, 43. PubMed ID: 17392997
    [No Abstract]   [Full Text] [Related]  

  • 26. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
    Steinhubl SR; Berger PB; Mann JT; Fry ET; DeLago A; Wilmer C; Topol EJ;
    JAMA; 2002 Nov; 288(19):2411-20. PubMed ID: 12435254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Estimated Glomerular Filtration Rate Decline on the Efficacy and Safety of Clopidogrel With Aspirin in Minor Stroke or Transient Ischemic Attack: CHANCE Substudy (Clopidogrel in High-Risk Patients With Acute Nondisabling Cerebrovascular Events).
    Zhou Y; Pan Y; Wu Y; Zhao X; Li H; Wang D; Johnston SC; Liu L; Wang C; Meng X; Wang Y; Wang Y;
    Stroke; 2016 Nov; 47(11):2791-2796. PubMed ID: 27738237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PCI and clopidogrel: antiplatelet responsiveness and patient characteristics.
    Grdinic A; Vojvodic D; Djukanovic N; Colic M; Grdinic AG; Ignjatovic V; Majstorovic I; Ilic V; Magic Z; Obradovic S; Ostojic M; Dolijanovic SP
    Acta Cardiol; 2011 Jun; 66(3):333-40. PubMed ID: 21744703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers.
    Fontana P; Nolli S; Reber G; de Moerloose P
    J Thromb Haemost; 2006 Apr; 4(4):813-9. PubMed ID: 16634751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin.
    Pettinella C; Romano M; Stuppia L; Santilli F; Liani R; Davì G
    Thromb Haemost; 2009 Apr; 101(4):687-90. PubMed ID: 19350112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet responses to several agonists and combinations of agonists in whole blood: a placebo controlled comparison of the effects of a once daily dose of plain aspirin 300 mg, plain aspirin 75 mg and enteric coated aspirin 300 mg, in man.
    May JA; Heptinstall S; Cole AT; Hawkey CJ
    Thromb Res; 1997 Oct; 88(2):183-92. PubMed ID: 9361371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Durability of platelet inhibition by clopidogrel.
    Gurbel PA; Bliden KP
    Am J Cardiol; 2003 May; 91(9):1123-5. PubMed ID: 12714161
    [No Abstract]   [Full Text] [Related]  

  • 35. Pantoprazole may enhance antiplatelet effect of enteric-coated aspirin in patients with acute coronary syndrome.
    Kasprzak M; Koziński M; Bielis L; Boinska J; Plazuk W; Marciniak A; Budzyński J; Siller-Matula J; Rość D; Kubica J
    Cardiol J; 2009; 16(6):535-44. PubMed ID: 19950090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Matetzky S; Shenkman B; Guetta V; Shechter M; Beinart R; Goldenberg I; Novikov I; Pres H; Savion N; Varon D; Hod H
    Circulation; 2004 Jun; 109(25):3171-5. PubMed ID: 15184279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals.
    Kovács EG; Katona E; Bereczky Z; Homoródi N; Balogh L; Tóth E; Péterfy H; Kiss RG; Edes I; Muszbek L
    Thromb Res; 2013 Apr; 131(4):320-4. PubMed ID: 23422285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)-1 inhibitor, in combination with clopidogrel in guinea pigs.
    Sakata C; Suzuki KI; Morita Y; Kawasaki T
    Eur J Pharmacol; 2017 Mar; 798():72-76. PubMed ID: 28095326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.